Showing results (851-860 of 876) with videos related to

Sort By:
Pageof 88
Internal Medicine Journal|July 7, 2026
Australasian chronic lymphocytic leukaemia consensus statement: 2026 updateSean McKeague, Joanna Katarzyna Czerwinski, Xavier Badoux, et al.
Leukemia & Lymphoma|December 6, 2021
Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphomaAhmad S Halwani, Carlos Panizo, Iris Isufi, et al.
Neuro-Oncology|December 1, 2023
Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 studyJacoline E C Bromberg, Samar Issa, Bronno van der Holt, et al.
The Biochemical Journal|June 22, 2022
PKN2 deficiency leads both to prenatal 'congenital' cardiomyopathy and defective angiotensin II stress responsesJacqueline J T Marshall, Joshua J Cull, Hajed O Alharbi, et al.
Regulatory Toxicology and Pharmacology : RTP|May 4, 2022
Read-across and new approach methodologies applied in a 10-step framework for cosmetics safety assessment - A case study with parabensGladys Ouedraogo, Camilla Alexander-White, Dagmar Bury, et al.
Blood Advances|November 1, 2021
Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignanciesConstantine S Tam, Meletios Dimopoulos, Ramon Garcia-Sanz, et al.
Leukemia Research|June 18, 2013
Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic deathJessica K Altman, Alfred Rademaker, Elizabeth Cull, et al.
The Biochemical Journal|February 11, 2022
Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivoAngela Clerk, Daniel N Meijles, Michelle A Hardyman, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 26, 2018
Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaJacqueline C Barrientos, Susan O'Brien, Jennifer R Brown, et al.
Nature Microbiology|July 12, 2024
Bacterial reprogramming of tick metabolism impacts vector fitness and susceptibility to infectionSourabh Samaddar, Agustin Rolandelli, Anya J O'Neal, et al.
Pageof 88